The immunohistochemical analysis for human endostatin also demonstrated that there was much stronger endostatin staining in tumor tissues treated with Ad-Endo plus dl1520 than in tissues treated with Ad-Endo alone, whereas no positive staining was observed in those tumor tissues treated with dl1520 alone or the medium control (Figure 5D upper row). The gene discussed is COL18A1; the disease is neoplasm.